{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:27:43Z","timestamp":1786429663529,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renal fibrosis, a common pathological endpoint in Chronic Kidney Disease (CKD), is closely associated with the accumulation of gut-derived uremic toxins, underscoring the therapeutic relevance of the gut-kidney axis. This study investigated the antifibrotic mechanism of Haikunshenxi Capsule (HKSX), a marine-derived drug, and its principal plant-derived metabolite, fucoidan (FPS), focusing on the Indoxyl Sulfate (IS)-Aryl Hydrocarbon Receptor (AhR) signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In an adenine-induced CKD rat model, HKSX treatment significantly improved renal function and attenuated tubulointerstitial fibrosis. Targeted metabolomics analysis revealed that HKSX modulated tryptophan metabolism and reduced the systemic IS accumulation. Mechanistically, immunofluorescence and Western blotting revealed that the elevated IS levels were associated with increased\n                      <jats:italic>AhR<\/jats:italic>\n                      nuclear accumulation and subsequent upregulation of Cytochrome P450 enzymes (\n                      <jats:italic>CYP1A1\/CYP1B1<\/jats:italic>\n                      ) in renal tubular cells. This aberrant signaling activation was associated with Epithelial-Mesenchymal Transition (EMT), characterized by loss of E-cadherin (E-cad) and gain of \u03b1-smooth muscle actin (\u03b1-SMA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HKSX treatment reduced\n                      <jats:italic>AhR<\/jats:italic>\n                      nuclear accumulation, downregulated CYP expression, and attenuated EMT.\n                      <jats:italic>In vitro<\/jats:italic>\n                      experiments using IS-stimulated HK-2 cells suggested that FPS attenuated activation of this pathway, with effects comparable to those of the specific\n                      <jats:italic>AhR<\/jats:italic>\n                      inhibitor CH223191 on AhR-mediated EMT-related changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, HKSX exerts a renal protective effect by reducing systemic uremic toxin accumulation and attenuating IS\/AhR signaling-associated EMT, supporting the therapeutic potential of HKSX against renal fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1819011","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:34:50Z","timestamp":1786426490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Haikunshenxi capsule alleviates renal fibrosis in chronic kidney disease via modulation of indoxyl Sulfate\u2013Aryl hydrocarbon receptor signaling"],"prefix":"10.3389","volume":"17","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangjie","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Nephrology, Affiliated Hospital of Nantong University, Yancheng Third People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoduan","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s11356-019-06931-z","article-title":"Fucoidan alleviates microcystin-LR-induced hepatic, renal, and cardiac oxidative stress and inflammatory injuries in mice","volume":"27","author":"AlKahtane","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1681\/ASN.0000000675","article-title":"Uremic toxins, CKD, and cognitive dysfunction","volume":"36","author":"Andrews","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/CIRCRESAHA.123.322875","article-title":"Activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney disease","volume":"133","author":"Balestrieri","year":"2023","journal-title":"Circ. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF03226377","article-title":"Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate","volume":"26","author":"Banoglu","year":"2001","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"Bello","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000476074","article-title":"Aryl hydrocarbon receptor activation in chronic kidney disease: role of uremic toxins","volume":"137","author":"Brito","year":"2017","journal-title":"Nephron"},{"key":"B7","first-page":"1553","article-title":"Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes","volume":"7","author":"Chen","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"154546","DOI":"10.1016\/j.phymed.2022.154546","article-title":"Yishen-Qingli-Huoxue formula attenuates renal fibrosis by inhibiting indoxyl sulfate via AhR\/snai1 signaling","volume":"108","author":"Chen","year":"2023","journal-title":"Phytomedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1646969","DOI":"10.3389\/fphar.2025.1646969","article-title":"Discontinuation versus continuation of renin-angiotensin system inhibitors in chronic kidney disease stage 3-5 patients: a systematic review and meta-analysis","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/17512433.2025.2532659","article-title":"Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy","volume":"18","author":"Colbert","year":"2025","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1080\/10408398.2022.2043823","article-title":"Structural characteristics and immunomodulatory effects of sulfated polysaccharides derived from marine algae","volume":"63","author":"Feng","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/toxins10050202","article-title":"Role of uremic toxins for kidney, cardiovascular, and bone dysfunction","volume":"10","author":"Fujii","year":"2018","journal-title":"Toxins (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the global Burden of Disease Study 2023","volume":"406","author":"GBD","year":"2025","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.3390\/biomedicines10092234","article-title":"Oral absorbent AST-120 is associated with compositional and functional adaptations of Gut Microbiota and modification of serum short and medium-chain fatty acids in advanced CKD patients","volume":"10","author":"Hsu","year":"2022","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e108448","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand","volume":"9","author":"Ichii","year":"2014","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"148071","DOI":"10.1016\/j.ijbiomac.2025.148071","article-title":"Review on seaweed derived sulfated and non-sulfated marine polysaccharides as multifunctional food ingredients: structure-function relationships, bioactivities and applications in functional foods","volume":"330","author":"John","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/ijms21072392","article-title":"Aryl hydrocarbon receptor activation and tissue factor induction by fluid shear stress and Indoxyl sulfate in endothelial cells","volume":"21","author":"Lano","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41598-024-51498-6","article-title":"Effects of AST-120 on mortality in patients with chronic kidney disease modeled by artificial intelligence or traditional statistical analysis","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e70426","DOI":"10.1002\/mco2.70426","article-title":"Aryl hydrocarbon receptor in health and disease","volume":"6","author":"Li","year":"2025","journal-title":"Medcomm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/md23040148","article-title":"New polyketides from a marine sponge-derived fungus, neopestalotiopsis sp., with anti-renal fibrosis activity","volume":"23","author":"Li","year":"2025","journal-title":"Mar. Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41522-025-00651-8","article-title":"High interindividual variability of indoxyl sulfate production identified by an oral tryptophan challenge test","volume":"11","author":"Lin","year":"2025","journal-title":"Npj Biofilms Microbiomes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"117098","DOI":"10.1016\/j.bcp.2025.117098","article-title":"Chidamide, a novel histone deacetylase inhibitor, alleviates renal fibrosis by suppressing the PI3K\/AKT signaling pathway","volume":"240","author":"Liu","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1524654","DOI":"10.3389\/fphar.2025.1524654","article-title":"Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.addr.2017.12.019","article-title":"Targeting renal fibrosis: mechanisms and drug delivery systems","volume":"129","author":"Nastase","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/md16040132","article-title":"Pharmacokinetic and tissue distribution of fucoidan from fucus vesiculosus after oral administration to rats","volume":"16","author":"Pozharitskaya","year":"2018","journal-title":"Mar. Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized placebo-controlled EPPIC trials of AST-120 in CKD","volume":"26","author":"Schulman","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/md9091664","article-title":"Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering","volume":"9","author":"Senni","year":"2011","journal-title":"Mar. Drugs"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/biom15121750","article-title":"Fucoidan therapy for extraintestinal diseases: targeting the microbiota\u2013gut\u2013organ axes","volume":"15","author":"Sun","year":"2025","journal-title":"Biomolecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/imna-d-24-00044","article-title":"Exploring enterotype characteristics of chronic kidney disease stages 3-5 based on the partitioning around medoids clustering algorithm","volume":"12","author":"Sun","year":"2025","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13287-021-02429-z","article-title":"Mesenchymal stem cells ameliorate renal fibrosis by galectin-3\/Akt\/GSK3\u03b2\/Snail signaling pathway in adenine-induced nephropathy rat","volume":"12","author":"Tang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12967-023-04455-2","article-title":"The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies","volume":"21","author":"Tang","year":"2023","journal-title":"J. Transl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"123072","DOI":"10.1016\/j.lfs.2024.123072","article-title":"Gut microbiota and renal fibrosis","volume":"357","author":"Tong","year":"2024","journal-title":"Life Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/diagnostics15010021","article-title":"The gut-kidney axis in chronic kidney diseases","volume":"15","author":"Tsuji","year":"2024","journal-title":"Diagnostics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.redox.2020.101530","article-title":"The aryl hydrocarbon receptor as a target of environmental stressors - implications for pollution mediated stress and inflammatory responses","volume":"34","author":"Vogel","year":"2020","journal-title":"Redox Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.pmbts.2019.03.011","article-title":"Use of fucoidan to treat renal diseases: a review of 15 years of clinic studies","volume":"163","author":"Wang","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1039\/d0fo03153d","article-title":"Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention","volume":"12","author":"Wang","year":"2021","journal-title":"Food Funct."},{"key":"B41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"Jama Intern Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"157060","DOI":"10.1016\/j.phymed.2025.157060","article-title":"Fucoidan alleviates renal fibrosis in mice via akkermansia muciniphila-mediated suppression of NEU1-TLR4-NFkappaB signaling axis","volume":"145","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2557514","DOI":"10.1080\/07853890.2025.2557514","article-title":"The gut-kidney axis in high-altitude hypoxia: pathophysiological mechanisms and the central role of hypoxia inducible factor","volume":"57","author":"Wu","year":"2025","journal-title":"Ann. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2402066","DOI":"10.1002\/advs.202402066","article-title":"Uremic toxin receptor AhR facilitates renal senescence and fibrosis via suppressing mitochondrial biogenesis","volume":"11","author":"Xie","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1749109","DOI":"10.3389\/fphar.2026.1749109","article-title":"Fucoidan as a renal protectant: mechanistic insights and therapeutic implications of endothelial glycocalyx targeting","volume":"17","author":"Xin","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.3390\/nu12103068","article-title":"Oligo-fucoidan improves diabetes-induced renal fibrosis via activation of Sirt-1, GLP-1R, and Nrf2\/HO-1: an in vitro and in vivo study","volume":"12","author":"Yu","year":"2020","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.ijbiomac.2022.04.192","article-title":"Protective effects of fucoidan against kidney diseases: pharmacological insights and future perspectives","volume":"209","author":"Zahan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.chom.2025.08.014","article-title":"Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease","volume":"33","author":"Zhang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1039\/d6fo00785f","article-title":"Fucoidan alleviates kidney fibrosis by shaping the gut microbiota and modulating tryptophan metabolism","volume":"17","author":"Zhang","year":"2026","journal-title":"Food Funct."},{"key":"B50","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1389557517666170927112621","article-title":"Recent advances in the discovery and development of marine natural products with cardiovascular pharmacological effects","volume":"18","author":"Zhou","year":"2018","journal-title":"Mini Rev. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1819011\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:34:51Z","timestamp":1786426491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1819011\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":50,"alternative-id":["10.3389\/fphar.2026.1819011"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1819011","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1819011"}}